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ABSTRACT Tetracycline (Tc) antibiotics have been put to new uses in the construction of artiﬁcial gene regulation systems,
where they bind to the Tet repressor protein (TetR) and modulate its afﬁnity for DNA. Many Tc variants have been produced,
both to overcome bacterial resistance and to achieve a broad range of binding strengths. To better understand TetR-Tc binding,
we investigate a library of 16 tetracyclines, using ﬂuorescence experiments and molecular dynamics free energy simulations
(MDFE). The relative TetR binding free energies are computed by reversibly transforming one Tc variant into another during
the simulation, with no adjustable parameters. The chemical variations involve polar and nonpolar substitutions along one entire
edge of the elongated Tc structure, which provides many of the protein-ligand contacts. The binding constants span ﬁve orders of
magnitude. The simulations reproduce the experimental binding free energies, when available, within the uncertainty of either
method (50.5 kcal/mol), and reveal many additional details. Contributions of individual Tc substituents are evaluated, along
with their additivity and transferability among different positions on the Tc scaffold; differences between D- and B-class repres-
sors are quantiﬁed. With increasing computer power, the MDFE approach provides an attractive complement to experiment and
should play an increasing role in the understanding and engineering of protein-ligand recognition.doi: 10.1016/j.bpj.2009.08.050INTRODUCTION
Tetracycline (Tc) is an important antibiotic, which binds to the
bacterial ribosome and blocks protein synthesis (1–3).
Although >1000 Tc variants have been synthesized, only
a handful can be used as broad-spectrum antibiotics for
humans and livestock. Widespread use has led to several
resistance mechanisms, including mutations in the bacterial
rRNA and export of Tc from the cell (1,4,5). It is thus impor-
tant to develop new Tcs that can evade resistance while
effectively inhibiting protein synthesis. Tc export from the
bacterial cell is controlled by the Tet Repressor protein
(TetR). In the absence of Tc, TetR binds to the bacterial
DNA as a homodimer and represses the resistance genes.
When Tc is present, it binds to TetR as a [Tc Mg]þ complex
with a nanomolar dissociation constant, inducing conforma-
tional changes that reduce the binding constant of TetR and
DNA by 6–10 orders of magnitude (6–8). TetR dissociates
from the DNA, triggering the expression of a membrane
export protein, TetA (1).
Today, the TetR-Tc system is of general interest because
of widespread application in molecular and cell biology as
a sensitive switch for target gene regulation (9–12). Both
the protein and the ligand have been engineered to give
modified gene regulation systems. Thus, directed evolution
has yielded mutant TetRs that are induced by specific Tcs,
including nonantibiotic variants (13). Mutants have been
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0006-3495/09/11/2829/10 $2.00obtained that have an inverse behavior: binding a Tc variant
enhances the DNA binding affinity (14,15). A small peptide
agonist was obtained recently, which can induce TetR as effi-
ciently as Tc (16,17). Functional TetRs have been con-
structed where the two subunits are fused into a single chain,
including one variant that has different affinities for specific
Tcs in its two binding pockets (18).
The main features of TetR-Tc recognition have been
revealed by crystallography (7,8,19) and biochemical mea-
surements (13,20–23). Crystal structures are available for
TetR in its induced state, in complex with several Tc variants
(5,19,24–26). The structure of noninduced TetR is known,
bound either to the operator DNA (7) or as apo-TetR (27).
Also available is a half-induced structure, with [Tc Mg]þ
bound to just one of the two monomers, which adopts the
induced conformation, whereas the other monomer is in the
noninduced conformation, with bound Tc but no associated
Mg2þ (28).
Despite the wealth of data, many important details are not
revealed by crystallography. Thus, Tc has two main tauto-
mers, which are hard to distinguish crystallographically,
but have very different charge distributions. Several side
chains around the binding pocket can adopt different orien-
tations and protonation states that are hard to distinguish.
An earlier study used special x-ray refinement methods and
free energy simulations to explore these degrees of freedom
in the bound and unbound states (29), and showed that they
are preorganized for Tc-TetR binding.
Here, we investigate the sources of TetR-Tc binding spec-
ificity, by comparing the TetR binding affinities of Tc and 15
variants. Again, the binding preferences are the result of
a competition between many different effects, including
2830 Aleksandrov et al.desolvation of protein and ligand, plasticity of the binding
site, and direct protein-ligand contacts. To elucidate these
effects, we use a combination of thermodynamic measure-
ments and molecular dynamics (MD) simulations. We
compare Tc variants by alchemically transforming one into
the other, during a series of MD simulations. We also
consider several point mutants of TetR. The transformation
of ligand or protein is done reversibly, both for the TetR-
ligand complex and for the isolated ligand or protein in solu-
tion, so that a binding free energy difference is obtained (30).
We refer to this technique as molecular dynamics free energy
simulations (MDFE) (30–34). Thanks to a recently devel-
oped force-field model for tetracyclines (35,36), the simula-
tions reproduce experimental binding free energy differences
to within the experimental error, 50.5 kcal/mol. Indeed,
a second goal of this work is to illustrate the maturity of
free energy simulations for molecular recognition (33,34).
An approach combining experiments and simulations is
especially valuable to elucidate the fine details of binding
specificity. With MDFE, atomistic structural information
and thermodynamic information are derived from the same
MD simulations. We can examine the contributions of indi-
vidual chemical groups to binding (such as methyl or
hydroxyl groups) and the transferability of such contributions
from one position to another on the Tc scaffold. We also
consider the additivity of effects arising when two groups
are added or removed at different positions. Group effects
are further characterized by their individual contributions to
the free energy changes, usually referred to as free energy
components (37–39). We consider solvent contributions, as
well as subtle differences between the D- and B-class Tet
Repressors (TetR(D) and TetR(B), respectively).
Our analysis also illustrates the modular structure of tetracy-
clines. Indeed, Tcs are elongated, fused-ring molecules, with
an upper and a lower edge (Fig. 1). The lower edge chelates
a metal ion and presents it to the TetR protein (24,40). The
Tc and TetR modifications considered here are mostly located
on the opposite, upper edge. They illustrate its role as a speci-
ficity edge, which tunes the strength of TetR binding. This
analysis should aid efforts to design further variants of Tc
and of the Tet Repressor, and to engineer improved and
more-diverse systems for artificial gene regulation.
METHODS
Binding measurements
TetR(D) was expressed and purified as described previously (27). Tetracy-
clines were dissolved in degassed H2O and used for a maximum of 24 h.
No degradation was detected during this time by measuring UV spectra and
binding constants to TetR(D). TetR(D)/[Tc Mg]þ binding constants were
obtained by fluorescence titration at 20C (Fluorimeter LS50B, PerkinElmer,
Boston, MA). The same buffer (5 mM MgCl2, 50 mM Tris/HCl pH 8.0,
150 mM NaCl) was used for all titrations. Protein solution (0.05–1 mM) in
buffer with sufficient Mg2þ-concentration to ensure complete [Tc Mg]þ for-
mation was titrated with equal amounts of tetracycline stock solutions
(1.5–4 mM) (compare (41)). Titration was performed at optimized wave-Biophysical Journal 97(10) 2829–2838lengths from excitation and emission spectra of the TetR(D)/[Mg Tc]þ
complexes. Recently, we described the method in detail (see methodA in (26)).
Molecular dynamics simulations
The crystal structure of the class D Tet Repressor (TetR(D)) was taken from
the Protein Data Bank (PDB), entry 2TRT (with bound Tc) (19). The simu-
lations included protein residues within a 24 A˚ sphere, centered on the Tc
binding site. In addition to crystal waters, a 24 A˚ sphere of water was over-
laid, and waters that overlapped protein, crystal waters, Tc, or Mg2þ, were
removed. Protein atoms between 20 A˚ and 24 A˚ from the sphere’s center
were harmonically restrained to their experimental positions. Simulations
were done with the SSBP solvent model (42,43), which treats the region
outside the 24 A˚ sphere as a uniform dielectric continuum, with a dielectric
constant of 80. This is reasonable, since most of the outer region is water.
Newtonian dynamics were used for the innermost region, within 20 A˚ of
the sphere’s center; Langevin dynamics were used for the outer part of the
sphere, with a 292 K bath. The CHARMM22 force field was used for the
protein (44) and the TIP3P model for water (45). Tetracyclines were
described with the force field developed previously (35,36). Electrostatic
FIGURE 1 Tetracycline (Tc) and the analogs studied in this work.
Tetracycline-Tet Repressor Binding 2831interactions were computed without any cutoff, using a multipole approxi-
mation for distant groups (46). Calculations were done with the CHARMM
program (47,48).
Alchemical MD free energy simulations (MDFE)
To compare TetR binding by Tc and an analog, Tc0, we use a standard ther-
modynamic cycle (33,49). The two vertical legs represent Tc (respectively,
Tc0) binding to TetR. The MDFE method follows the horizontal legs, and
reversibly transforms Tc into Tc0 during a series of MD simulations. For
the lower leg, we simulate [Tc Mg]þ in the center of a 24 A˚ radius water
sphere, surrounded by a dielectric continuum representing bulk solvent
(42). For the upper leg, we simulate a portion of the [Tc Mg]þ-TetR
complex, solvated by the same 24 A˚ water sphere and embedded in the
same dielectric continuum. Portions of TetR outside the 24 A˚ sphere are
expected to contribute very little to the binding free energy difference
(43). In each simulation system, the energy function can be expressed as
a linear combinations of Tc and Tc0 terms,
UðlÞ ¼ U0 þ ð1  lÞUðTcÞ þ lU

Tc
0
; (1)
where l is a coupling parameter and U0 represents interactions between parts
of the system other than Tc. In our implementation, which uses the
CHARMM program, this energy form is obtained by explicitly modifying
selected force-field parameters at each l-value and by manually excluding
unwanted interatomic interactions (through the CHARMM exclusion state-
ment). The free energy derivative with respect to l has the form
vG
vl
ðlÞ ¼ UðTc0 Þ  UðTcÞ
l
; (2)
where the brackets indicate an average over an MD trajectory with the
energy function U(l) (33,49). We gradually mutated Tc into Tc0 by changing
l from zero to one. The successive values of l were 0.001, 0.01, 0.05, 0.1,
0.2, 0.4, 0.6, 0.8, 0.9, 0.95, 0.99, and 0.999. The free energy derivatives were
computed at each l-value from a 100-ps MD simulation, or window; the last
80 ps of each window were used for averaging. A complete mutation runthus corresponded to 12 windows and 1.2 ns of simulation. Three runs
were performed in each direction (Tc into Tc0 and the reverse), starting
from equilibrated structures separated by 1 ns of dynamics. The derivatives
are used to obtain DG, using trapezoidal integration, except for van der
Waals contributions close to the endpoints of the mutation (l ¼ 0.0–0.001
and 0.999–1.0). For these endpoint contributions, analytical integration
was used (50). The total CPU time for a single MDFE run was ~48 h on
a recent, 64-bit, desktop machine (3 GHz Intel processor with 4 Mbytes
of cache, using a single core).
Accurate uncertainty estimation with MDFE is difficult and expensive
(51–53). A widely-used approach is to perform multiple runs and measure
the dispersion between runs. Although this seems plausible, it neglects
some forms of systematic error, and can actually lead to an overestimated
uncertainty. In particular, it is well known that runs performed in opposite
directions (forward and backward transformations; l increasing or
decreasing) exhibit systematic hysteresis effects (54–56). Thus, we use an
error estimator that considers pairs of runs, one in each direction, forming a
forward/backward pair (40,57,58). In previous work, these forward/backward
averages were much more reproducible than the individual values. The uncer-
tainty is taken to be their standard deviation (usually obtained from three
forward/backward pairs, totaling 7.2 ns). In a few cases, we considered
only half of each window, yielding artificially shortened runs; the effect on
the overallDG values was comparable to our uncertainty estimates, indicating
that our run lengths are reasonable. (For a more detailed discussion of conver-
gence and some examples, see the Supplementary Material in (40).)
Almost all of the tetracycline variants were produced by directly modi-
fying Tc. For the largest ligand variations, however, a two-step transforma-
tion was used. For example, 9-amino-6-deoxy-6-demethyl-Tc was obtained
from 6-deoxy-6-demethyl-Tc, and 9-amino-8-chloro–6-deoxy-6-demethyl-
Tc was obtained from 9-amino-6-deoxy-6-demethyl-Tc. In a few cases,
multiple pathways were compared. For example, 6-deoxy-6b-methyl-Tc
was obtained in three different ways: either from 6-deoxy-6-demethyl-Tc,
from 6-deoxy-6a-methyl-Tc, or from 6-deoxy-5-hydroxy-Tc; the three
free energy estimates (2.3, 2.5, 2.6 kcal/mol) agree within the esti-
mated statistical uncertainty (50.2 kcal/mol for this ligand; Table 1). In
other cases where two or more pathways were compared, the variations inTABLE 1 Tetracyclines binding to TetR: experiment versus simulations
DDGMDFE DDGexptl
Tc variant DGprot
y DGsol
y TetR(D) TetR(D)z TetR(B)x
4-Dedimethylamino 3.4(0.6) 1.2(0.1) 4.6(0.7) — 4.8(0.6)
4-Epi 2.7(0.4) 0.1(0.1) 2.8(0.4) — 3.4(0.4)
5-Hydroxy 0.6(0.3) 1.0(0.3) 0.4(0.4) 0.0(0.4) 0.1(0.5)
6-Deoxy-5-hydroxy 1.1(0.9) 1.0(0.3) 2.1(0.9) 1.5(0.5) 1.2(0.4
6-Methylene-5-hydroxy 1.3(0.9) 0.1(0.3) 1.4(0.9){ — 1.2(0.3)
6-Deoxy-6a-methyl 2.8(0.2) 5.1(0.1) 2.4(0.2) — —
6-Deoxy-6b-methyl 1.4(0.3) 0.2(0.2) 1.3(0.4){ — 0.4(0.5)
6-Demethyl 2.2(0.2) 1.5(0.2) 0.7(0.2) — 1.8(0.6)
6-Deoxy-6-demethyl 0.9(0.2) 0.8(0.1) 1.8(0.2) 1.5(0.5) 0.5(0.6)
Anhydro-Tc 4.7(0.8) 1.7(0.3) 2.9(0.9) 2.4(0.4) 2.1(0.4)
7-Chloro 2.2(0.1) 3.0(0.1) 0.8(0.1) 0.5(0.5) 0.6(0.6)
8-Chloro 0.9(0.4) 1.7(0.1) 0.8(0.4) — —
8-Methyl 1.4(0.3) 0.8(0.1) 0.6(0.3) — —
9-Amino-6-deoxy-6-demethyl 3.6(0.3) 4.0(0.2) 0.4(0.4){ — 0.7(0.7)
9-Amino-8-chloro-6-deoxy-6-demethyl 2.7(0.3) 2.0(0.2) 0.7(0.4){ — 0.5(0.5)
Relative binding free energies (kcal/mol), with Tc as a reference. The Tc-TetR(D) binding free energy is 12.4 kcal/mol (this work). Experimental values are
from Lederer et al. (41) or this work.
yColumns 2–3 are the free energy to reversibly modify Tc, either in complex with TetR(D) (DGprot) or in solution (DGsol). For clarity, the free energy to modify
Tc in vacuum has been subtracted in each case (see main text). The binding free energy change can be written as DDG ¼ DGprot – DGsol. A negative DDG
means the variant binds more strongly than Tc. Experimental and MDFE error bars are in parentheses.
z(TetR(D)).
x(TetR(B)).
{Estimated using two sequential transformations of the ligand (see Methods).Biophysical Journal 97(10) 2829–2838
2832 Aleksandrov et al.the free energies were consistent with the estimated uncertainties (e.g., for
6-deoxy-6a-methyl-Tc; data not shown).
Free energy component analysis
The contribution of an individual atom i (that is not part of the ligand) to the
free energy derivative can be calculated by writing the energy function as
UðlÞ ¼
X
i
Ui0ðlÞ þ
X
i<j
Uij þ UligðlÞ; (3)
where Ui0(l) contains the interaction energy terms between atom i and the
ligand, Uij represents the interactions between i and atoms not in the ligand,
and Ulig represents interactions within the ligand. Only the terms Ui0 and Ulig
depend on l. Thus, atom i contributes a term
vGi=vl ¼ hvUi0=vlil (4)
to the free energy derivative. The numerical integration is linear, so the
numerical integral is equal to the sum of the integrals of the individual
vGi/vl. Summing over groups of atoms or residues, one obtains the free
energy contribution directly associated with each group. In the same way,
one can obtain the free energy contribution associated with specific energy
terms, e.g., the Coulomb or van der Waals terms in the energy function,
either for a specific group or for the whole system (except the ligand itself).
We refer to the component arising from the Coulomb term as the electro-
static component. Free energy components should be interpreted with
care, since the values obtained depend on details of the calculation, such
as the precise pathway employed (38,39). The alchemical pathway used
here, transforming one tetracycline into another, is thought to provide the
most useful components (38,39).
RESULTS
MDFE yields binding free energies with chemical
accuracy
We begin by comparing experimental and computed binding
free energy differences, to establish the accuracy of the simu-
lations. Indeed, Table 1 reports relative binding free energies
for 16 tetracyclines. The experimental TetR(D) binding free
energy for Tc, taken as a reference, is 12.45 0.1 kcal/mol
(this work). The Tc modifications involve positions 4–9 on
the Tc scaffold (Figs. 1 and 2). For six of the Tcs, binding
to the D-class repressor, TetR(D), was measured in this
work, using fluorescence titration (see Methods). For theBiophysical Journal 97(10) 2829–2838other 10 Tcs in Table 1, either the molecule was not readily
available or its fluorescence properties were not suitable. For
13 of the Tcs, the experimental binding affinity for the
homologous repressor, TetR(B), is known (59) (last column
in Table 1). MDFE results are given for each Tc variant,
binding to TetR(D). We established earlier that Tc prefers
its zwitterionic tautomer (N4 protonated, O3 deprotonated;
see Fig. 1), both in solution and in complex with TetR
(29,35). We assume the variants considered here are also
zwitterionic, since they have the same A ring as Tc (for Tc
ring labels, see Fig. 1). This assumption is supported by
the good agreement between experiment and simulations.
Fig. 3 plots the computed versus the experimental binding
free energies. For the various Tcs binding to TetR(D), the
agreement is excellent, with a root mean-square (RMS)
deviation of just 0.44 kcal/mol. This deviation is averaged
over five binding free energy values; it is comparable to
the statistical uncertainty of experiment and simulations,
50.5 kcal/mol on average. In four cases, the experimental
binding is stronger than the computed binding; however,
the differences remain small and within the statistical uncer-
tainty of the method. Note that the Tc-TetR(D) affinities
were measured after the simulations were done. Thus,
MDFE predicts the Tc-TetR(D) binding free energies with a
high accuracy and precision.
The inset in Fig. 3 shows all 16 ligands, taken from their
respective MDFE simulations. The 16 protein backbone
structures were superimposed, and the resulting ligand
conformations collected. Only the main, four-ring scaffold
of each ligand is shown, for clarity. We see that the ligand
variations produce only small shifts in the ligand position
within its binding pocket. For two Tc variants, 6-deoxy-5-
hydroxy-Tc and 7-chloro-Tc, TetR(D)-ligand x-ray structures
are available (PDB entries 2O7O and 2FJ1, respectively)
(24,26), to which the MDFE structures can be compared.
Comparing PDB No. 2O7O to the structures from the end
of the Tc / 6-deoxy-5-hydroxy-Tc transformation, for
example, gives an overall RMS coordinate deviation of
0.89 A˚ for protein backbone atoms (excluding those that are
restrained during the simulation) and 0.59 A˚ for the ligandFIGURE 2 Overview of the Tc-TetR complex (left) and
closeup of the binding site (right). The N-terminal, DNA
binding domains are at the bottom of the left-hand view.
Secondary structure elements belonging to monomer 1
(respectively, 2) are red (blue). A magnesium ion and asso-
ciated waters are shown as spheres. Important polar residues
are shown in ball-and-stick representation. Hydrophobic
residues are shown as lines. Primed residues belong to
monomer 2. The surface of the hydrophobic pocket created
by these residues is shown in yellow. The Tc rings are
labeled; selected atoms are numbered (as in text).
Tetracycline-Tet Repressor Binding 2833(deviations averaged over the last 200 ps of simulation). For
the Tc / 7-chloro-Tc case, the backbone RMS deviation
between the MDFE structure and the 2FJ1 x-ray structure is
1.21 A˚ (0.87 A˚ for the ligand). These deviations are small,
and typical of current MD simulations; they are comparable
to those observed for a recent simulation of the Tc-TetR(D)
complex: 0.75 A˚ for the backbone and 1.05 A˚ for atoms close
to the Tc ligand (29).
For seven Tcs, experimental data are available for TetR(B)
binding, but not for TetR(D), so that a precise comparison to
MDFE is not possible. In the five cases where the experi-
mental TetR(B) and TetR(D) binding free energies are both
available, they have an RMS deviation of 0.49 kcal/mol.
Four of the five deviations are very small (0.3 kcal/mol or
less), whereas 6-deoxy-6-demethyl has a 1 kcal/mol devia-
tion. Comparing the MDFE results for TetR(D) to the same
five experimental TetR(B) results gives a slightly higher
RMS deviation of 0.69 kcal/mol. In three cases (including
6-deoxy-6-demethyl-Tc), the difference between experiment
(TetR(B)) and MDFE (TetR(D)) is >0.8 kcal/mol. For
6-deoxy-6-demethyl-Tc, MDFE and experiment agree
closely. For aTc and 6-deoxy-5-hydroxy-Tc, the MDFE/
TetR(B) differences are 0.8 and 0.9 kcal/mol, respectively,
whereas the experimental D/B differences are 0.3 kcal/mol;
i.e., smaller but with the same sign as the MDFE result. For
FIGURE 3 Experimental and computed binding free energies for 16 tetra-
cycline variants are compared. Results are given relative to Tc. Experimental
and computed error bars are shown. The solid line corresponds to a perfect
match between experimental and computed values; dashed lines are
1 kcal/mol above/below. All the MDFE simulations employ the D-class re-
pressor. The experimental data correspond to either TetR(D) (large dots) or
the homologous TetR(B). (Inset) All 16 ligands, superimposed based on the
protein structure. For clarity, only the main, fused-ring scaffold is shown; Tc
is black, the other ligands are gray.aTc binding to TetR(B), preliminary experimental results
suggest that the published affinity (41) may not be fully reli-
able (W. Hinrichs, unpublished data). In any case, the exper-
imental/MDFE differences for these two ligands are still
within the statistical uncertainty of the two methods. Overall,
MDFE can be compared qualitatively to the TetR(B) experi-
ments, and can be used to predict the larger TetR(D)/TetR(B)
differences (which are considered in detail further on).
Hydroxyl editing at positions 5 and 6
In this and the next two sections, we consider specific Tc
variations and their effect on TetR binding. The ligands in
Table 1 provide opportunities to sample the effect of
hydroxyl groups in different contexts, at positions 5 and
especially 6. Table 1 reports the binding free energy changes,
DDG, along with the individual free energy changes in the
protein complex and in solution, DGprot and DGsolv. The
free energy change for the transformation in vacuum has
been subtracted, effectively removing the contribution of
intraligand interactions, and allowing the free energy changes
to be interpreted in terms of protein-ligand and solvent-ligand
interactions. Below, we make use of a further decomposition
of the free energy changes into components (see Methods).
These correspond to contributions from either the van der
Waals or the Coulomb (or electrostatic) term in the energy
function, which arise either from the entire protein or a specific
amino acid.
Introducing a hydroxyl at position 5 hardly changes the
binding affinity, either for TetR(B) or TetR(D) (see 5-hy-
droxy-Tc in Table 1). In the protein, the 5-hydroxyl makes
a hydrogen bond to the Gln116 side chain, which also inter-
acts with the 2,3-ketone-enolate group of Tc (Fig. 2). This
hydrogen bond replaces a hydrogen bond to water, and
balances the 5-hydroxyl desolvation penalty.
In contrast, a hydroxyl at position 6 lacks a hydrogen-
bonding partner in the protein; the shortest distance to a polar
TetR group is to the Gln116 side chain, 4.9 A˚ away. The
hydrophobic residues Pro105 and Val113 are closer by
(Fig. 4 A). Thus, the binding free energy of 6-deoxy-6a-
methyl-Tc is 2.4 5 0.2 kcal/mol higher than that of Tc.
This is consistent with estimates of free energy contributions
of nonionic hydrogen bonds (60–62). Intuitively, it repre-
sents the penalty to remove the polar, hydroxyl group from
water. Comparing the free energy changes in the protein
and in solution, DGprot and DGsolv, we see that the largest
free energy component is a large, positive, electrostatic
contribution to DGsolv: þ5.1 kcal/mol, opposing removal
of the hydroxyl from solvent (Table 1). The electrostatic
component in the protein is also positive but much smaller:
þ2.8 kcal/mol. Note that the nearby Pro105 and Val113
have negligible components (0.1 kcal/mol each). Thus, the
binding free energy change can indeed be quantitatively
ascribed to lost electrostatic interactions in the unbound
state.Biophysical Journal 97(10) 2829–2838
2834 Aleksandrov et al.FIGURE 4 MD structures of selected complexes (diver-
gent stereo). (A) Tc and 6-deoxy-Tc complexes. The Tc
complex is black (ligand and protein side chains); the
6-deoxy-Tc complex is gray. The ligands and nearby
hydrophobic residues are shown as sticks, the protein back-
bones as ribbons. The Tc 6-methyl is labeled. (B) Tc and
6-demethyl-Tc complexes; same representation. (C)
6a-methyl-6-deoxy-Tc and 6b-methyl-6-deoxy-Tc com-
plexes. The 6a-methyl-6-deoxy-Tc complex is black; the
6b-methyl-6-deoxy-Tc complex is gray.Six-deoxy-6a-methyl-Tc is predicted to be one of the stron-
gest-binding Tc variants (Table 1). No experimental binding
free energy is available, but we may compare the hydroxyl
effect in other contexts. The difference between 6-demethyl-
Tc and 6-demethyl-6-deoxy-Tc is 2.5 kcal/mol (MDFE,
TetR(D)) or 2.3 kcal/mol (experiment, TetR(B)). Thus, the
hydroxyl contribution is transferable from Tc to 6-demethyl-
Tc. Not only the total effect, but the separate van der Waals
and electrostatic contributions to DGprot and DGsolv, are very
similar (not shown). Comparing 5-hydroxy-Tc and 6-deoxy-
5-hydroxy-Tc gives a somewhat lower difference of
1.5 kcal/mol for TetR(D) binding (2.5 kcal/mol with MDFE),
or 1.3 kcal/mol for TetR(B). Finally, with aTc, we have re-
moved the 6-hydroxyl, but also the 6-hydrogen, leading to a pla-
nar C ring. The binding free energy gain is 2.45 0.4 kcal/mol
(2.95 0.9 kcal/mol with MDFE). This is consistent with the
6-hydroxyl effect in other contexts, and supports the idea that
the binding variations are governed by desolvation.
Hydrophobic groups at positions 6–8 increase Tc
binding
Our ligand set includes two pairs that differ by a 6-methyl
group (in the a-orientation): Tc/6-demethyl-Tc andBiophysical Journal 97(10) 2829–28386-deoxy-6a-methyl-Tc/6-deoxy-6-demethyl-Tc. The two
binding free energy differences are 0.7 and 0.6 kcal/mol,
favoring the methylated form. The latter value is an average
over two sets of MDFE simulations that follow two distinct
pathways: a direct transformation and an indirect transforma-
tion, via Tc; the two simulations yield 0.5 and 0.7 kcal/mol,
respectively, in good mutual agreement. The affinity
decrease upon demethylation can be attributed to the favor-
able desolvation of the methyl when it is present, and its
burial in a hydrophobic pocket in the complex (Fig. 2 and
Fig. 4 B). It represents an example of solvent interactions
driving binding, as well as another example of transferability
of a substituent effect from one context (Tc) to another
(6-deoxy-Tc). If the 6-methyl is replaced by a methylene,
binding is reduced by a similar amount, 0.7 kcal/mol
(compare 6-deoxy-5-hydroxy and 6-methylene-5-hydroxy).
The methylene is similar to the 6-methyl in size and polarity,
but it is in plane with the C ring and has a different orienta-
tion with respect to the protein environment. Finally, if the
6-methyl is moved from the 6a orientation (as in Tc) to
the 6b orientation, the effect on binding is no longer favor-
able, because of steric conflict between the methyl and
Val113 (Fig. 4 C). Indeed, for this transformation, the van
Tetracycline-Tet Repressor Binding 2835der Waals component is precisely equal to the total binding
free energy change, 1.3 5 0.5 kcal/mol; the electrostatic
component is zero.
Six-demethylation is the only ligand change that has
a substantially different effect in TetR(D) and TetR(B): see
6-demethyl-Tc and 6-deoxy-6-demethyl-Tc in Table 1. For
these two Tc variants, as well as 6-deoxy-6bmethyl-Tc, the
TetR(D)/TetR(B) difference is ~þ1 kcal/mol, indicating
that the 6-methyl makes superior interactions with TetR(B)
(or the 6-demethyl variants make inferior interactions). In
TetR(D), the 6-methyl contacts Val113, Leu117, Leu131, and
Ile134, with methyl-methyl distances of 4.5, 4.1, 5.3, and
4.1 A˚, respectively (Fig. 4). The largest group contributions
to the binding free energy change are van der Waals contribu-
tions from Leu117 and Leu131 (0.3 kcal/mol each, favoring
6-demethyl-Tc). The Val113 and Ile134 components are zero.
In TetR(B), Leu117 and Leu131 are conserved, but Ile134 is re-
placed by a leucine, whereas Val113 is replaced by a leucine.
Changing Val113 to Leu introduces an additional CH2, which
is expected to contribute ~0.2 kcal/mol in additional van der
Waals interaction energy (assuming a 4 A˚ distance between
the Tc 6-methyl and the new CH2). This is partly offset by
CH2-solvent interactions in the unbound state. Additional
effects such as improved packing of the 6-methyl neighbors
in TetR(B) (or inferior packing around the 6-demethyl vari-
ants) must account for the rest of the 1 kcal/mol binding
free energy gain. To determine the precise origin would
require extensive TetR(B) simulations. For the 11 other Tc
variants (which are not 6-demethylated), the mean TetR(D)/
TetR(B) difference is just þ0.2 kcal/mol; this small, average
increase in TetR(B) binding may be due to statistical noise.
Methylation or chlorination at positions 7 or 8 all have
a similar effect, increasing TetR(D) binding by 0.8 kcal/mol,
very similar to 6-methylation. The 8-methyl and 8-chloro
groups make favorable contacts with the side chains of
Leu131, Met177
0
, Leu174
0
, Leu170
0
, and Val173
0
; primed resi-
dues belong to monomer 2 (Fig. 4). Interestingly, the
favorable effect of 8-Cl is enhanced when an amino group
is introduced at the adjacent position 9. Thus, 9-amino-8-
Cl-6-deoxy-6-demethyl-Tc binds 1.1 kcal/mol more strongly
than 9-amino-6-deoxy-6-demethyl-Tc. This represents a
0.3 kcal/mol enhancement for 8-chlorination when the
9-amino group is present. The enhancement is a solvent effect,
arising from the DGsolv free energy terms, since the DGprot
values for 8-chlorination are the same with or without the
9-amino group (0.9 kcal/mol; Table 1). It corresponds to a
partial desolvation by 8-Cl of the polar, 9-amino group: when
8-Cl is present, the 9-amino:solvent interactions in the unbound
state are reduced and it is easier to desolvate the ligand.
Tc’s 4-dimethylamino group contributes strongly
to TetR binding
The largest binding changes are due to variations at position
4, involving the 4-dimethylamino group. Switching C4 tothe epimeric configuration results in a drastic decrease of
Tc binding. The experimental binding free energy increase
for TetR(B) is 3.4 5 0.4 kcal/mol; the computed value
for TetR(D) is 2.8 5 0.4 kcal/mol. Two hydrogen bonds
between 4-epi-Tc and Asn82 are formed in the MD struc-
ture, similar to the Tc case. In the TetR(D):Tc complex,
His64 interacts with both the O3 and O2
0 oxygens of Tc;
in the 4-epi-Tc complex, the O3-His
64 interaction is main-
tained, but the O2
0-His64 distance is too long for a hydrogen
bond (3.7 A˚). Previous free energy simulations predicted
that His64 spends almost half of its time in the singly-
protonated state and the rest in the doubly-protonated state
(29). In our simulations, we treat it as doubly-protonated,
which may lead to overestimated interactions. The agree-
ment with experiment suggests that the error cannot be
too large; however. Both Tc and 4-epi-Tc also interact
with Gln116, through O3 and O2
0. Overall, the polar interac-
tions of Tc and 4-epi-Tc are similar, except for the lacking
His64-O2
0 hydrogen bond with 4-epi-Tc. The steric inter-
actions of 4-epi-Tc with TetR(D) are somewhat poorer;
this is reflected by the van der Waals component of the
Tc/4-epi-Tc binding free energy difference: 3.2 kcal/mol,
out of the 2.8 kcal/mol total (the electrostatic component
is 0.4 kcal/mol).
Removing the 4-dimethylamino group altogether reduced
binding below the sensitivity of the experimental method
(59). Nevertheless, the experimental binding free energy
can be inferred with the help of the 4-dedimethylamino-anhy-
dro-Tc (4-ddma-aTc) value, þ2.7 5 0.3 kcal/mol. Indeed,
aTc and Tc have the same structure around positions 3–5,
and the same interactions with TetR. Therefore, the binding
free energy difference between Tc and 4-ddma-Tc should
be close to the difference between aTc and 4-ddma-aTc,
4.85 0.6 kcal/mol. The computed Tc/4-ddma-Tc difference
is 4.65 0.7 kcal/mol. Thus, the simulations support the idea
that the 4-dimethylamino contribution is transferable between
Tc and aTc, and show that TetR(B) and TetR(D) behave
similarly.
Removing the 4-dimethylamino group eliminates several
interactions. First, favorable van der Waals contacts are
lost between the two methyls and nearby Phe86, Ile134,
Val137, and Ser138 (Fig. 2). Second, unfavorable methyl-
water contacts in the unbound state are removed, stabilizing
that state. Third, the Tc N4 makes a hydrogen bond to Asn82,
which is lost with 4-ddma-Tc. It is interesting to compare
the effect of an Asn82Ala mutation, which also eliminates
this interaction, and which reduces Tc binding by 2.0 5
1.3 kcal/mol; this last free energy change should be viewed
as the difference between a strong Asn82-dimethylamino
interaction in the bound state and a weaker Asn82-water
interaction in the unbound state. Experimentally, an
Asn82Ser mutation reduces binding by a similar amount,
2.7 kcal/mol (63). Fourth, 4-ddma-Tc has a protonated O3,
unlike zwitterionic Tc, leading to weaker interactions with
Gln116 and His64. Mutating Gln116 to alanine reduces TcBiophysical Journal 97(10) 2829–2838
2836 Aleksandrov et al.binding by 4.5 5 0.6 kcal/mol; mutating His64 to Ala
reduces Tc binding by 2.6 5 0.9 kcal/mol.
DISCUSSION AND CONCLUSION
Elucidating protein-ligand binding remains an important
challenge. Although experiments, especially crystallography,
provide essential information, the most powerful approach,
arguably, is to combine experiments with MD simulations.
Indeed, with MDFE, structural and thermodynamic informa-
tion are derived from the same simulations. MDFE has
matured considerably, giving chemical accuracy in this study.
To obtain this accuracy, two general difficulties had to be
overcome. The first is force-field availability and accuracy.
This is a concern whenever the ligands are not standard
biopolymers and are not part of the main, existing force fields
(64). Notice that general force fields are being developed and
improved, such as the general AMBER force field (65) and the
very recent, general CHARMM force field (66). For tetracy-
clines, a specific force field was developed earlier (35,36).
Care was taken to maintain a good consistency and balance
between the new parameters and the other, standard parts of
the CHARMM force field. The second difficulty is the exis-
tence of multiple free energy minima, corresponding to
different conformations and protonation states. An earlier
study used special x-ray refinement methods and free energy
simulations to explore Tc tautomers, His64 protonation states,
and the orientation of important protein side chains (29). With
this groundwork, MDFE gave an RMS deviation between
simulations and experiments of 0.44 kcal/mol for the binding
free energies of Tc and five variants. The measurements for
these complexes were performed after the simulations. A
similar deviation (0.35 kcal/mol) was obtained earlier for six
tetracyclines binding to the 30S ribosomal particle (40). For
Tc and two variants (7-chloro-Tc and 6-deoxy-5-hydroxy-
Tc), the MD structures could be compared to x-ray complexes,
giving good agreement. A hallmark of MDFE is that this
agreement is obtained without any adjustable parameters.
The mean precision of simulations and experiment is very
similar,50.5 kcal/mol for the binding free energies from all
three datasets in Table 1: TetR(D) with MDFE or experi-
ment, and TetR(B). The low MDFE uncertainty is obtained
by running over 7 ns of dynamics for each ligand transforma-
tion. The uncertainty estimate is supported in several cases
by repeated calculations that employed different pathways
to transform one ligand into another. There is also an
unknown, systematic error introduced by assuming His64
to be doubly-protonated, whereas earlier simulations pre-
dicted that it spends almost half of its time in the singly-
protonated state (29). This error cannot be too large,
however, since the free energies agree with experiment. In
addition, the His64 position is in good agreement with exper-
iment in the three cases where x-ray structures are available
(see above), with RMS deviations of 0.9–1.0 A˚, comparable
to the protein backbone deviations.Biophysical Journal 97(10) 2829–2838After validation by the fluorescence titration experiments,
the simulations provided new data, filling several gaps in
the experimental dataset, for Tc variants that were harder to
synthesize, whose fluorescence properties were unsuitable,
or whose binding was too weak to be measured. Thus,
TetR(D) binding free energies were obtained for 10 new tetra-
cyclines, including three for which no TetR(B) measurement
was available. One of these is 6-deoxy-6a-methyl-Tc, pre-
dicted to be the strongest binder of all, along with anhydrote-
tracycline, with a binding free energy 2.4 5 0.2 kcal/mol
better than Tc. Good accuracy was maintained even for the
largest ligand variations (4-epi-Tc, 4-dedimethyl-Tc). Struc-
tural models were produced for all 16 complexes, only three
of which have known x-ray structures. TetR(B) and TetR(D)
binding were compared for 12 Tc variants, showing that for
most (but not all) of the Tc substitutions, either protein can
be used to understand the effect on binding. Finally, the simu-
lations filled another gap by providing alanine-scanning
mutagenesis data for a few positions around the Tc binding
pocket (His64, Asn82, and Gln116).
The main value of the simulations, however, is not to
substitute for experiment, but to provide a deeper, atomistic
understanding of the system. Thus, the inset in Fig. 3 shows
a superposition of the 16 ligands studied here, based on their
common TetR(D) partner. We see that the ligands bind to
TetR in the same manner, so that ligand and protein reorga-
nization effects largely cancel. Indeed, most of the variations
in binding strength could be interpreted rather simply, either
by changes in the ligand solvation in the unbound state, or by
the making or breaking of protein-ligand contacts in the
complex. Because the binding mode is conserved, the
contacts for any of the ligands can be inferred from any of
the three available protein-ligand crystal structures. This
situation, with limited structural reorganization when the
ligand is varied, also makes it easier to use and interpret
a component analysis of the binding free energies (39).
One case where the strength of the contacts is harder to infer
is that of the 6-methyl group interacting with TetR(B), where
small amino-acid sequence changes, relative to TetR(D),
increase the ligand binding by 1 kcal/mol. In most cases,
however, protein-ligand van der Waals or hydrogen-bond
contacts were found to be transferable among different posi-
tions on the upper Tc edge and among different contexts.
Thus, a methyl or chlorine substitution has almost the
same effect at positions 6–8. Not only is the overall binding
free energy preserved, but the van der Waals and electrostatic
components in the protein and in the solvent as well. In
a similar way, hydroxyl additions at positions 5 and 6 had
the same effect in several different contexts, which could
be interpreted as an increased desolvation penalty.
Evidently, effects such as these can be described with much
more confidence with not only experiments but also MDFE
structures and free energies in hand. This analysis illustrates
the increasing potential of the method, and should aid efforts
to design further variants of Tc and of the Tet Repressor.
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